Company news: Pfizer and PhRMA

Share this article:
Pfizer and Shanghai Pharmaceutical Co. are partnering for a possible Pfizer product launch in China. The companies already co-promote pediatric flu vaccine Prevenar in China.

PhRMA announced its board leadership for the coming year. Sanofi-Aventis CEO Christopher Viehbacher will continue as board chairman of the trade group, while Lilly chief John Lechleiter becomes chairman-elect and Celgene CEO Robert Hugin board treasurer. Viehbacher stepped into the role last year when then-chairman Jeff Kindler abruptly left Pfizer.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.

IRS struggles with device tax

A Treasury report says the IRS is having trouble identifying who owes it money.

White House proposes Hobby Lobby alternative

A proposal by the Obama administration Friday seeks to keep contraception accessible and coverage approval at arm's length for employees of religious non-profits.